Vibrant’s Lyme antibody testing is performed on our proprietary silicon chip microarray platform.
Results are reported on a validated index scale (0–20) based on assay signal intensity, this is a semi-quantitative, assay-specific metric.
Because the silicon chip microarray platform does not use indirect fluorescent antibody (IFA) or IFA-like methodology, dilution titers (e.g., 1:80, 1:160) are not reported.